Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Valvular Heart Disease

  Free Subscription


26.02.2024

1 Am Heart J
9 Am J Cardiol
5 Ann Thorac Surg
3 Cardiol Young
1 Circ Cardiovasc Interv
1 Circ Cardiovasc Qual Outcomes
3 Circ Genom Precis Med
1 Circ Heart Fail
3 Eur Heart J
1 Heart
7 Int J Cardiol
1 Pediatr Cardiol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. KIM M, Ahn JM, Kang DY, Kim MJ, et al
    Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial.
    Am Heart J. 2024;269:167-178.
    PubMed         Abstract available


    Am J Cardiol

  2. BRAUNWALD E
    Hypertrophic Cardiomyopathy: A Brief Overview.
    Am J Cardiol. 2024;212S:S1-S3.
    PubMed         Abstract available

  3. ABRAHAM MR, Abraham TP
    Role of Imaging in the Diagnosis, Evaluation, and Management of Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2024;212S:S14-S32.
    PubMed         Abstract available

  4. HUTT E, Desai MY
    Medical Treatment Strategies for Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2024;212S:S33-S41.
    PubMed         Abstract available

  5. IRELAND CG, Ho CY
    Genetic Testing in Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2024;212S:S4-S13.
    PubMed         Abstract available

  6. BALI AD, Malik A, Naidu SS
    Treatment Strategies for Hypertrophic Cardiomyopathy: Alcohol Septal Ablation and Procedural Step-by-Step Technique.
    Am J Cardiol. 2024;212S:S42-S52.
    PubMed         Abstract available

  7. SALBERG L
    Hypertrophic Cardiomyopathy: The Patient Perspective-Turning Tragedy into Action.
    Am J Cardiol. 2024;212S:S83-S86.
    PubMed        

  8. MARON BJ, Rowin EJ, Maron MS
    Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023.
    Am J Cardiol. 2024;212S:S77-S82.
    PubMed         Abstract available

  9. MARON MS, Rowin EJ, Maron BJ
    The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2024;212S:S64-S76.
    PubMed         Abstract available

  10. SCHAFF HV, Juarez-Casso FM
    Treatment Strategies for Hypertrophic Cardiomyopathy: Surgical.
    Am J Cardiol. 2024;212S:S53-S63.
    PubMed         Abstract available


    Ann Thorac Surg

  11. SA MP, Jacquemyn X, Awad AK, Brown JA, et al
    Valve-Sparing Aortic Root Replacement With Reimplantation vs Remodeling: A Meta-analysis.
    Ann Thorac Surg. 2024;117:501-507.
    PubMed         Abstract available

  12. KIM ER, Lee C, Lee CH, Cho SH, et al
    Long-term Outcomes of Polytetrafluoroethylene Bicuspid Pulmonary Valve Replacement.
    Ann Thorac Surg. 2024;117:535-541.
    PubMed         Abstract available

  13. ROBERTS SH, Kaneko T
    Simplest Explanations to a Complex Problem: Does Hospital Volume Explain Variability in TAVR Cost?
    Ann Thorac Surg. 2024;117:533-534.
    PubMed        

  14. OKADA A, Beckmann E, Rocher EE, Fukui M, et al
    Preprocedural computed tomography planning for surgical aortic valve replacement.
    Ann Thorac Surg. 2024 Feb 19:S0003-4975(24)00121.
    PubMed         Abstract available

  15. DEROO S, Aldea GS
    5-year COMMENCE Data Highlights Excellent Surgical Outcomes in Aortic Valve Replacement.
    Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00119.
    PubMed        


    Cardiol Young

  16. KASKI JP, Kammeraad JAE, Blom NA, Happonen JM, et al
    Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy: A position statement from the AEPC Working Group on Basic Science, Genetics and Myocardial Disease and the AEPC Working Group on Car
    Cardiol Young. 2024;34:469.
    PubMed        

  17. BRAUNLIN E, Bay L, Guffon N, Yang M, et al
    Natural history of cardiac findings in mucopolysaccharidosis type I: report from an international registry.
    Cardiol Young. 2024;34:401-411.
    PubMed         Abstract available

  18. KARA KA, Arslanoglu E, Yigit F, Arkan C, et al
    The prognostic significance of early troponin levels in patients undergoing aortic ridge surgery.
    Cardiol Young. 2024;34:301-307.
    PubMed         Abstract available


    Circ Cardiovasc Interv

  19. SHECHTER A, Lee M, Kaewkes D, Patel V, et al
    Implications of Mitral Annular Calcification on Outcomes Following Mitral Transcatheter Edge-to-Edge Repair.
    Circ Cardiovasc Interv. 2024;17:e013424.
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  20. ZHANG Y, Liu M, Zhang C, Zou Y, et al
    Role of Biomarkers of Myocardial Injury to Predict Adverse Outcomes in Hypertrophic Cardiomyopathy.
    Circ Cardiovasc Qual Outcomes. 2024;17:e010243.
    PubMed         Abstract available


    Circ Genom Precis Med

  21. HERMIDA A, Ader F, Millat G, Jedraszak G, et al
    NEXN Gene in Cardiomyopathies and Sudden Cardiac Deaths: Prevalence, Phenotypic Expression, and Prognosis.
    Circ Genom Precis Med. 2024;17:e004285.
    PubMed         Abstract available

  22. HAYESMOORE JBG, Bowman M, Shannon N, Blair E, et al
    A Promoter Deletion Confirms That MYBPC3 Haploinsufficiency Is Sufficient to Cause Hypertrophic Cardiomyopathy in Humans.
    Circ Genom Precis Med. 2024;17:e004134.
    PubMed        

  23. SHAUER A, Horowitz-Cederboim S, Mor-Shaked H, Durst R, et al
    Calmodulinopathy Associated Long QT Syndrome, Hypertrophic Cardiomyopathy With Excessive Trabeculation in a 14-Year-Old Girl Presenting With Ventricular Fibrillation.
    Circ Genom Precis Med. 2024 Jan 23:e004163. doi: 10.1161/CIRCGEN.123.004163.
    PubMed        


    Circ Heart Fail

  24. LEGEAI C, Coutance G, Cantrelle C, Jasseron C, et al
    Waitlist Outcomes in Candidates With Rare Causes of Heart Failure After Implementation of the 2018 French Heart Allocation Scheme.
    Circ Heart Fail. 2024 Feb 1:e010837. doi: 10.1161/CIRCHEARTFAILURE.123.010837.
    PubMed         Abstract available


    Eur Heart J

  25. WU J, Zafar MA, Elefteriades JA
    Decision-making in aortic disease.
    Eur Heart J. 2024;45:633-634.
    PubMed        

  26. MESSIKA-ZEITOUN D, Iung B, Baumgartner H
    The year in cardiovascular medicine 2023: the top 10 papers in valvular heart disease.
    Eur Heart J. 2024 Feb 21:ehae090. doi: 10.1093.
    PubMed        

  27. LURZ P, Kresoja KP
    Surgical or percutaneous treatment of mitral regurgitation: clip or cut?
    Eur Heart J. 2024 Feb 21:ehae084. doi: 10.1093.
    PubMed        


    Heart

  28. UBBEN T, Frerker C, Fujita B, Rosenkranz S, et al
    Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair.
    Heart. 2024 Feb 22:heartjnl-2023-323473. doi: 10.1136/heartjnl-2023-323473.
    PubMed         Abstract available


    Int J Cardiol

  29. ALTIBI AM, Sapru A, Ghanem F, Zhao Y, et al
    Impact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;400:131790.
    PubMed         Abstract available

  30. MUSUMECI B, Tini G, Biagini E, Merlo M, et al
    Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
    Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
    PubMed         Abstract available

  31. DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
    Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
    Int J Cardiol. 2024;400:131768.
    PubMed         Abstract available

  32. HIRAM R
    The duration of atrial fibrillation might be associated with right heart disease severity.
    Int J Cardiol. 2023 Dec 28:131689. doi: 10.1016/j.ijcard.2023.131689.
    PubMed        

  33. BOURG C, Lee KC, Donal E
    Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
    Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
    PubMed        

  34. DI MAURO M, Guarracini S, Mazzocchetti L, Capuzzi D, et al
    Transcatheter bicaval valve system for the treatment of severe isolated tricuspid regurgitation. Features from a single-Centre experience.
    Int J Cardiol. 2024 Feb 16:131864. doi: 10.1016/j.ijcard.2024.131864.
    PubMed         Abstract available

  35. FATIMA K, Uddin QS, Tharwani ZH, Kashif MAB, et al
    Concomitant transthyretin cardiac amyloidosis in patients undergoing TAVR for aortic stenosis: A systemic review and meta-analysis.
    Int J Cardiol. 2024 Feb 15:131854. doi: 10.1016/j.ijcard.2024.131854.
    PubMed         Abstract available


    Pediatr Cardiol

  36. LOU Y, Zhao B, Pan M, Huang L, et al
    Quantitative Analysis of Morphology and Function in the Fetal Heart with Severe Tricuspid Regurgitation by Speckle Tracking Imaging.
    Pediatr Cardiol. 2024 Feb 23. doi: 10.1007/s00246-024-03454.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.